Gabriela Fernández-Cuervo1, Kirsten A. Tucker2, Scott W. Malm3, Kyle M. Jones4, and Mark D. Pagel4
1Pharmaceutical Sciences, University of Arizona, Tucson, AZ, United States, 2Chemistry and Biochemistry, University of Arizona, Tucson, AZ, United States, 3Pharmacy, University of Arizona, Tucson, AZ, United States, 4Biomedical Engineering, University of Arizona, Tucson, AZ, United States
Synopsis
We have designed and
synthesized new MRI agents that quantitatively detect β-galactosidase and
β-glucuronidase activities by measuring changes in chemical exchange saturation
transfer (CEST). Based on a modular approach, we incorporated the enzymes’
respective substrates to a salicylate moiety with a spontaneously
disassembling, chromogenic spacer via
a carbamate linkage. This design furnished highly selective diamagnetic CEST
agents that detected and quantified enzyme activities of glycoside hydrolase
enzymes. Michaelis-Menten enzyme kinetics studies were performed by monitoring
catalyCEST MRI signals, which were validated with UV-vis assays.
Purpose
An imaging protocol, termed catalyCEST MRI, can detect
enzyme activity in vitro1-7
and in vivo.8,9 Unfortunately,
many enzymes may be inactive or have sluggish activity when catalyzing the
cleavage to a substrate that is directly linked to an imaging agent. Therefore,
we sought to expand this platform technology by incorporating a spacer between
the diamagnetic CEST agent and glycoside moiety via a carbamate linkage. To
test this approach, we developed diamagnetic CEST agents that can detect β-galactosidase
(β-gal) and β-glucuronidase (β-gus) glycoside hydrolase enzymes. Methods
The CEST agents were synthesized, purified and
characterized using standard methods. β-gal
and β-gus from E. coli were added to substrate
concentrations between 0.05 – 50 mM at 37.0±0.2oC. CEST MRI studies were performed with a 7T
Bruker Biospec MRI scanner with a 72 mm quadrature transceiver coil. A
CEST-FISP acquisition protocol was used to acquire a series of 107 images after
selective saturation was applied using a continuous wave pulse at 3 µT power
for 4 s with frequencies ranging from 15 to -15 ppm.5 FISP
acquisition parameters included TR: 3.196 ms; TE: 1.598 ms; excitation flip
angle: 30°; centric
encoding; number of averages: 1; matrix: 128x128; field of view: 6.4x6.4 cm;
in-plane spatial resolution: 500x500 mm; slice thickness: 1 mm. The temporal
resolution of acquiring one image with one selective saturation frequency was
5.441 s. The total time to acquire 107
images for a full CEST spectrum was 9:42 min.
For Michaelis-Menten kinetics studies, 75 image
sets to generate a 62-point CEST spectrum were collected after selective
saturation was applied using a continuous wave pulse at 3 µT power for 4 s with
frequencies ranging from 15 to -15 ppm. The same FISP parameters were
used. The total acquisition time was 4.5
hours. CEST spectra were
analyzed by fitting three Lorentzian line shapes to account for the direct
saturation of water and the CEST signals at 4.25 ppm and 9.25 ppm.5
The Lorentzian line shape fitting automatically referenced the bulk water
chemical shift at 0 ppm, negating the effect of B0 inhomogeneities
in the CEST MR images.
To perform UV-vis enzymatic microplate assays, serial
dilutions of appropriate substrate were incubated with 0.125 U of β-gal or 250
U of β-gus enzyme at 37.0 °C for 16 hours.
Formation of product was detected by optical absorbance at 425 nm every
2 minutes.
Results
The agents were synthesized with a 5-25% overall yield. Before enzyme hydrolysis, we observed two CEST
signals from each agent at 9.25 ppm and 4.25 ppm. In the presence of enzyme, the signal at 9.25
ppm did not change while the signal at 4.25 ppm disappeared, corresponding to
the conversion of the agent into 4-amino salicylic acid. The ratio of the CEST peaks effectively
detected enzyme activity in a concentration–independent manner. Temporal studies showed that the CEST signal at
4.25 decreased in the presence of the corresponding enzyme for each agent, but remained
consistently high in the presence of inhibited enzyme, no enzyme or the
presence of the other enzyme for each agent.
The temporal
disappearance of the CEST signal at 4.25 ppm showed good fitting by the
Hanes-Woolf plot (R2 = 0.80 for β-gal and 0.76 for β-gus)
demonstrating that the CEST agent followed Michaelis-Menten enzyme kinetics theory. These plots were used to determine the
catalytic efficiency and other kinetics parameters for each enzyme. β-gal and β-gus had similar KM
constants for the respective contrast agent, demonstrating similar binding
affinities for their ligands. β-gal has a faster kcat value than
β-gus, indicating faster glycosidic cleavage of the β-gal-detecting agent.
We repeated Michaelis-Menten
kinetics studies of the agents by monitoring the optical absorption of the
spontaneously disassembling spacer. For agents
responsive to β-gal, the KM, kcat and
catalytic efficiency constants were comparable within an order of magnitude
between the analyses performed with catalyCEST MRI and UV-vis studies. For
agents responsive to β-gus, the KM and kcat values
differed by about two orders of magnitude between each analysis method. This
difference was attributed to the minor systematic error caused by the competitive
inhibition of β-gus by free glucuronic acid. Discussion
We
have shown that diamagnetic CEST agents can detect and quantify the enzyme
activities of glycoside hydrolase enzymes. Incorporating the spontaneously
disassembling spacer provided a tri-modular design for detecting enzyme
catalysis. Acknowledgements
No acknowledgement found.References
1. Yoo B,
et al. J Am Chem Soc 2006;128:14032-14033.
2. Yoo B,
et al. Contrast Media Mol Imaging 2007;2:189-198.
3. Li Y, et al.
Contrast Media Mol Imaging 2011:6;219-228.
4. Yoo B, et
al. Tetrahedron Lett 2009:50;4459-4462.
5. Hingorani
DV, et al. J Am Chem Soc 2013;135:6396-6398.
6. Hingorani
DV, et al. Contrast Media Mol Imaging 2016;11:130-138.
7.
Fernández-Cuervo G, et al. Chembiochem 2016;17:383-387.
8. Yoo B, et
al. Magn Reson Med 2014:71;1221-1230.
9. Sinharay S,
et al. Magn Reson Med 2016, DOI:10.1002/mrm.26278